Drug Companies Push For Predictability In Naming System Over Reservations

Teva Pharmaceuticals is warning FDA that drug companies could potentially abuse a program for the "reserving" of proprietary names, and the Pharmaceutical Research and Manufacturers of America is urging FDA to add more predictability to applicants rather than setting up a proprietary name reservation system. The agency in July opened a public docket to discuss the possibility of reserving proprietary names for companies once the names have been tentatively accepted by the agency. This initiative was included in the Prescription...